The Ebola Virus continues to ravage the 3 Western African countries of Liberia, Guinea, and Sierra Leone even as Americans seem to be losing interest. The World Health Organization has published the following statistics:
Guinea 2793 cases 1797 deaths
Liberia 8263 cases 3515 deaths
Sierra Leone 10030 cases 2977 deaths
21,086 cases 8,289 deaths
There are several vaccines being developed. Three pharmaceutical companies with vaccines in the pipeline are:
Johnson and Johnson
This vaccine is in Phase I trials where it is being given to a few volunteers to check for safety and side effects. Two shots must be given 1-2 months apart.
Glaxo Smith Kline
This vaccine is ready for Phase II clinical trials in February. It will be given to a larger group of people, probably in Africa. It is made from a harmless cold virus and coated with proteins from 2 strains of the Ebola virus-Zaire and Sudan. It seems to be well tolerated and induces antibodies against Ebola.
Mercks Phase I trial was stopped for a short period when volunteers experienced joint pain. It has now resumed using a lower dose and seems to be well tolerated.